Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies’ Development of Rapid Test for COVID-19 Neutralizing Antibodies is Cited to Demonstrate over 90% Sensitivity and 100% Specificity
November 09, 2021 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19...
Clip Health (formerly Luminostics) Announces Company Rebranding, Immediate Product Pipeline
September 27, 2021 06:00 ET | Clip Health
MILPITAS, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Clip Health™, a fast-growing healthtech company and diagnostics innovator, today announced its DBA name change and company rebrand from its...
22157.jpg
Global Blood Screening Markets Report 2021: Market is Expected to Grow at a CAGR of 6.9% from 2020 to 2027 to Reach $3.56 Billion
June 24, 2021 04:33 ET | Research and Markets
Dublin, June 24, 2021 (GLOBE NEWSWIRE) -- The "Blood Screening Market by Product (Reagents & Kits, Instruments, Software), Technology (NAAT [Real-time PCR], ELISA [CLIA, FIA, CI], Rapid Tests,...
AvantGen's logo-final.JPG
AvantGen receives an award from the NIH/RADx to commercialize its anti-SARS-CoV-2 nucleocapsid antibodies for ultra-high sensitivity lateral flow assay development
May 25, 2021 06:00 ET | AvantGen Inc
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- AvantGen, a San Diego-based biotech, is a leader in the use of yeast display technology for human and rabbit monoclonal antibody discovery and...
22157.jpg
Worldwide In-vitro Diagnostics Industry to 2027 - Players Include Danaher, Thermo Fisher Scientific and Abbott Laboratories Among Others
April 01, 2021 06:08 ET | Research and Markets
Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "In-vitro Diagnostics Market (IVD Market) by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests,...
Abingdon_logo.png
AbC-19™ Rapid Test used in UK BioBank COVID-19 Antibody Study
March 29, 2021 02:00 ET | Abingdon Health PLC
AbC-19™ Rapid Test used in UK BioBank COVID-19 Antibody Study The study will investigate the long-term health effects of long COVID York, U.K. 29 March 2021: The UK-RTC is pleased to announce that...
teräcero round logo rbg 600.png
A new stage in COVID-19 testing – Teracero Pharma reports receiving the first authorization for a COVID-19 serology rapid test under the Minister of Health’s Interim Order
March 17, 2021 14:00 ET | Teracero Pharma Inc.
nal von Minden GmbH’s NADAL COVID-19 IgG/IgM Test is highly sensitive and specific to antibodies against SARS-CoV-2, requires no special training, and can provide results within 10 minutes MONTREAL,...
Teracero Pharma annonce avoir reçu la première autorisation au Canada en vertu de l'arrêté d’urgence du ministre de la Santé pour un test sérologique rapide pour la COVID-19
March 17, 2021 14:00 ET | Teracero Pharma Inc.
Le test NADAL COVID-19 IgG/IgM de nal von Minden GmbH est très sensible et spécifique aux anticorps contre le SRAS-CoV-2, ne nécessite aucune formation particulière et fournit des résultats en 10...
Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test
February 16, 2021 05:30 ET | Luminostics
Luminostics’s Clip COVID Rapid Antigen Test uses a smartphone-based analyzer to obtain results in 30 minutes from nasal swabs in decentralized settingsClip COVID’s emergency use authorization (EUA) in...
PRPO logo.png
Precipio Launches COVID-19 Antibody Testing at Point-of-Care
January 28, 2021 09:30 ET | Precipio, Inc.
NEW HAVEN, Conn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that following receipt of an Emergency Use Authorization from the FDA...